We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SKYQ:NASDAQSky Quarry Inc. Analysis

Data as of 2026-05-27 - not real-time

$2.40

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Sky Quarry (SKYQ) is trading at $2.40, well below its DCF‑derived fair value of $2.97, suggesting a potential price discount. However, the stock’s technical picture is mixed: the 20‑day SMA ($3.79) sits above current price, the 200‑day SMA ($3.78) also trails, and the RSI at 34 indicates modest oversold conditions, while a bearish MACD histogram reinforces downward momentum. Volatility is extreme at 160% over the past 30 days and volume is decreasing, amplifying short‑term risk. Fundamentally, the company is distressed – it reports negative gross (‑44.8%) and operating margins, a staggering debt‑to‑equity ratio of 573, and a PE of 48 versus an industry average of 20, yet it shows a positive free cash flow of $1.95 M against negative operating cash flow. Recent news highlights a strategic multi‑party MOU and an RFP for its 180‑million‑barrel oil sands asset, which could unlock value if commercialized, but these developments remain speculative. The combination of a low market cap, high beta (~1), and sector exposure to oil‑and‑gas cycles creates a fragile risk profile. Investors should weigh the discount to intrinsic value against the pronounced operational and financial headwinds.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 6/10

Key Factors

  • Bearish MACD and price below short‑term SMA
  • Extreme 30‑day volatility
  • Decreasing trading volume

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Strategic MOU and oil‑sands RFP potential
  • Price discount to DCF fair value
  • Continued financial distress and high debt

Long Term

> 3 years
Neutral
Model confidence: 4/10

Key Factors

  • Long‑term asset upside if commercialization succeeds
  • Persistent regulatory and environmental headwinds
  • Heavy leverage limiting upside capture

Key Metrics & Analysis

Financial Health

Revenue Growth-100.00%
Profit Margin-181.62%
P/E Ratio48.0
ROE-193.22%
ROA-23.32%
Debt/Equity572.93
P/B Ratio2.4
Op. Cash Flow$-1898184
Free Cash Flow$2.0M
Industry P/E20.7

Technical Analysis

TrendNeutral
RSI34.3
Support$2.30
Resistance$7.19
MA 20$3.79
MA 50$5.05
MA 200$3.78
MACDBearish
VolumeDecreasing
Fear & Greed Index92.34

Valuation

Fair Value$2.97
GradeUndervalued
TypeValue

Risk Assessment

Beta0.99
Volatility160.75%
Sector RiskHigh
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.